Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells
about
Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravisAllelic diversity is generated by intraexon sequence exchange at the DRB1 locus of primatesA specific HLA-DP beta allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritisNetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequenceMutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.Quantitative predictions of peptide binding to MHC class I molecules using specificity matrices and anchor-stratified calibrations.Identification of a motif for HLA-DR1 binding peptides using M13 display librariesA systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approachFlanking p10 contribution and sequence bias in matrix based epitope prediction: revisiting the assumption of independent binding pocketsIdentification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping dataExpression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgiaIdentification of residues necessary for clonally specific recognition of a cytotoxic T cell determinant.HLA class II allelic variation and susceptibility to pemphigus vulgarisInteraction of an immunodominant epitope with Ia molecules in T-cell activation.Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility.Leishmania major infection of inbred mice: unmasking genetic determinants of infectious diseases.HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris: review of the literature and potential applications for the development of a specific immunotherapy.Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophreniaReassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptidesAlternative splicing of HLA-DQB transcripts and secretion of HLA-DQ beta-chain proteins: allelic polymorphism in splicing and polyadenylylation sitesPrediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis.Two genetically identical antigen-presenting cell clones display heterogeneity in antigen processingRelative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses.Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.Energetic asymmetry among hydrogen bonds in MHC class II*peptide complexes.The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination.Induced T cell cytokine production is enhanced by engineered nanoparticles.Distinct recognition by two subsets of T cells of an MHC class II-peptide complex.Comparative analysis of B- and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein 10.A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus.Structural analysis of the HLA-DR, -DQ, and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype.Binding interactions between peptides and proteins of the class II major histocompatibility complex."Troy-bodies": recombinant antibodies that target T cell epitopes to antigen presenting cells.Perspective on antigen processing and presentation.Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competitionIdentification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.Structural basis of antigen recognition by T lymphocytes. Implications for vaccines.Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.Antigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases.
P2860
Q24561626-37471E56-FC96-4EB8-89B5-4888DF6F2A7EQ24562873-CE07B5E2-7539-47E5-A5B3-DAABCF20AE27Q24601796-40007B37-F22B-4522-BD2A-B580B0F2F83CQ28469279-5D43E9F0-6106-435A-984C-6DDD4463CD22Q30442735-F929A253-A923-42D0-8E86-6243A273D0E6Q31974998-90F9B4CA-BF2C-439E-A67C-963211724A4CQ33191162-64C94EE7-777E-42D3-845E-CCF6AA9DA6F8Q33326976-5C571A18-3821-46F0-9964-DBE13EB7709DQ33377255-8F622E30-E412-435D-942E-CC49EAB20B13Q33399896-FD97FFD0-50E3-4371-B0A6-F3558D0539B8Q33567585-124EDCDA-89BB-439B-976C-512801968213Q33572540-F57D5FCE-A40F-41D4-9E5C-EFB33680CE15Q33574546-57C20344-7FCD-407A-9694-9FA02B013AB6Q33632555-565C8BDF-8CFE-42AB-AE37-99A141AA5909Q33640310-580DD9F2-106E-4F84-8A10-B878C5031478Q33685715-5B796BB1-DE98-489C-B91B-C8F4A5D1208AQ33751646-0F524EBC-7E1F-4F8E-8BF3-2AF41D7ED3F9Q33773196-09E3F0A3-4C35-49F5-A490-16A9C02D452FQ33816489-96C237EC-F10C-4889-987A-4E3E571891ADQ33835593-4472D1FB-E5CF-453C-8E9C-CCD1359E0C88Q33854050-B32C8C98-E7DC-4702-A784-4B488E69DCC7Q33854151-6B040C01-3727-4149-88E3-D3D95CCD767FQ33863544-39226A5E-41C0-4136-966A-16794DBBE7C4Q33920167-628D2536-2D04-4953-BDC5-C09B8444BA8CQ33930509-4FED8492-C89F-4C13-AF13-AFEB2A6F04BCQ33943143-DB0EBDCC-4F75-4794-A616-612C6CAB1E66Q34036445-ECA4B49C-8974-4A87-BF22-2A1E5E66B038Q34066093-80D65135-92AB-44AB-819C-9364F95EF389Q34145568-FFF75533-1BF3-4DC5-A765-53256ECF2C00Q34249153-CE482D62-00C6-4869-9984-6DB21DAD7F8AQ34297492-B55EC90B-9753-4F20-A780-8F3805E788E9Q34540061-BB6F22F5-BDD2-487C-B260-5E96FD8536B1Q34560537-D59A806A-F455-44C5-A649-BD5830357B93Q34792432-6D6A4204-F251-478B-8A6C-4D2A77992D27Q34982899-3673CB6A-1C67-4D53-A1D4-E56C642B4CC4Q35156297-5D197C2E-2D26-45F7-B225-350BFC606AC1Q35591477-A706CF47-D66A-4EA1-8E19-8D270EB6C17EQ35593962-194D9CEE-14C6-4A9D-90EB-B271002303CEQ35605653-A7356406-D142-4F46-97C6-FA04988A55D5Q35637379-E1610780-2DCC-42E6-AF29-79004CE3AA1F
P2860
Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells
description
article publié dans la revue scientifique Nature
@fr
scientific article published in Nature
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в Nature в липні 1987
@uk
name
Structural characteristics of ...... Ia and recognition by T cells
@en
Structural characteristics of ...... Ia and recognition by T cells
@nl
type
label
Structural characteristics of ...... Ia and recognition by T cells
@en
Structural characteristics of ...... Ia and recognition by T cells
@nl
prefLabel
Structural characteristics of ...... Ia and recognition by T cells
@en
Structural characteristics of ...... Ia and recognition by T cells
@nl
P2093
P356
P1433
P1476
Structural characteristics of ...... Ia and recognition by T cells
@en
P2093
Craig Miles
Howard M. Grey
John A. Smith
Sonia Colon
Søren Buus
P2888
P304
P356
10.1038/328395A0
P407
P577
1987-07-01T00:00:00Z
P6179
1056438800